Tobacco use in populations with behavioral health conditions is a critical health disparity. Moreover, patients with severe mental illness, such as schizophrenia, are three times more likely to smoke than the general population. While smoking is a modifiable risk factor, many individuals with SMI typically are not treated for tobacco use disorder
This webinar will explore the burden of tobacco use among individuals SMI, including the tobacco industry’s influence, culture of treatment of tobacco use disorder, and misconceptions about treatment. Additionally, this webinar will explore opportunities and possibilities for treatment through evidenced based models and case studies.